The U.S. Court of Appeals for the 5th Circuit temporarily blocked the abortion pill mifepristone from being sold online and transported to patients through the mail by restoring in-person screening ...
WASHINGTON – The Supreme Court on May 4 reinstated mail-order access to the widely used abortion drug mifepristone, a temporary decision that gives the justices more time to consider the issue. The ...
A British bride who had black paint thrown over her just before she walked down the aisle broke down in tears Tuesday as she ripped her sister-in-law’s attempts to justify the spiteful attack. Gemma ...
A federal appeals court late Friday blocked the ability of doctors to prescribe the abortion pill mifepristone through telehealth and dispensed through the mail. A three-judge panel on the 5th U.S.
Louisiana challenged rule concerning abortion drug mifepristone Appeals court backed Louisiana in unanimous decision May 1 (Reuters) - A U.S. appeals court on Friday temporarily blocked a federal rule ...
The court order, in a lawsuit by the state of Louisiana, pauses a Food and Drug Administration regulation that greatly expanded access to the abortion pill mifepristone. By Pam Belluck Pam Belluck ...
Supreme Court Justice Samuel A. Alito Jr. on Monday issued an order that temporarily allows patients to continue accessing a widely used abortion pill through the mail. The decision came after two ...
MIRABEL, QC, May 6, 2026 /CNW/ - The world is changing rapidly. In response, Canada's new government is focused on what we can control. We are building a stronger economy with an ambitious plan to ...
A federal appeals court on Friday blocked the mailing of the abortion pill mifepristone under current Food and Drug Administration (FDA) rules, a move the court acknowledged would, "as a practical ...
WASHINGTON (AP) — The Supreme Court on Monday restored broad access to the abortion pill mifepristone, blocking a ruling that had threatened to upend one of the ...
BROOMFIELD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results